openPR Logo
Press release

Neuropathic Pain Management Market: Growing Incidence of Chronic Ailments to Propel the Global Market

06-03-2020 03:32 PM CET | Health & Medicine

Press release from: Transparency Market Research

Neuropathic Pain Management Market: Growing Incidence

Global Neuropathic Pain Management Market: Overview

The global neuropathic pain management market is prognosticated to see a steep growth in the coming years, bolstered by the surge in peripheral nerve problems. Trauma, infections, or dysfunction in the central nervous system is the root cause of neuropathic pain. Neuropathic pain management are techniques used to alleviate and control the issue. This includes medications such as anticonvulsants, antidepressants, and anesthetics. The emergence of advanced pain management devices and techniques such as non-opioid pain treatment solutions, analgesic pumps, etc.

Read Report Overview - https://www.transparencymarketresearch.com/neuropathic-pain-management-market.html

This report provides an exhaustive analysis of the global neuropathic pain management market, with focus on market opportunities and possible constraints, along with the latest trends driving the market.

Global Neuropathic Pain Management Market: Notable Developments

The global neuropathic pain management market is predicted to be influenced by a number of trend in the in the healthcare industry. Some of the key developments that are anticipated to affect the global neuropathic pain management market are as follows:

Request a PDF Sample - https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=65489

Introduction of Grants towards Research

An IASP Developing Countries Project, which continued to March 2018, was launched in January 2018 by the International Association for Pain Studies (IASP), with the aim of increasing pain education and practice in developing countries by providing sufficient grants. Eellan Sivanesan, MD received the Chronic Pain Medicine Research Grant 2018 in November 2018 from the American Society for Regional Anesthesia and Pain Medicine (ASRA). The increasing awareness and funding activotoes offered by institutes and government organizations in this manner is expected to boost the global neuropathic pain management market.

Vendors Gaining Approval for New Drugs

A new NDA application for Lasmiditan for migraine, with or without aura, migraine stage, for adults was presented by Eli Lilly and the company in November 2018 to the US Food and Drugs Administration (USFDA). This key development is anticipated to augur well for the global neuropathic pain management market in the coming years.

Prominent players operating in the global neuropathic pain management market are Medtronic plc, Eli Lilly and Company, Boston Scientific Corporation, Abbott Laboratories, AstraZeneca PLC, ecton, Dickinson and Company, Pfizer Inc., and Novartis AG.

Request for Analysis of COVID19 Impact on Neuropathic Pain Management Market - https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=65489

Global Neuropathic Pain Management Market Dynamics

The growing incidence of chronic ailments such as diabetes and other cardiovascular diseases is a key factor propelling the global neuropathic pain management market. According to statistics from the World Health Organization (WHO), over 422 million in 2014 were suffering from diabetes. This number is expected to magnify in the coming years, leading to high demand for neuropathic pain management.

The enhancing healthcare infrastructures, growing resource allocation towards research by pharma giants, and novel drug discovery techniques are further fuelling the global neuropathic pain management market.

However, the side effects of drugs such as steroids and opioids may hamper market demand to some extent. Additionally, the high cost of branded drugs could limit the growth of the neuropathic pain management market to some extent. These market limitations, however, may be overcome by the key trend of generic drugs, increased spending on healthcare, and rising demand for minimally invasive techniques.

Asia Pacific to Register Brisk Growth with High Diabetes Incidence

North America is projected to be a dominant region in the global neuropathic pain management market in the coming years. This could be accounted to the region’s developed and established healthcare infrastructure, swift adoption of technological advances in pain management techniques, and presence of leading vendors in the neuropathic pain management market.

At the same time, Asia Pacific neuropathic pain management market is expected to show promising growth opportunities in the coming years. The growing prevalence of diseases such as diabetes and cardiovascular ailments is contributing to the growth of this regional market.

Contact

Transparency Market Research,

90 Sate Street, Suite 700,

Albany, NY 12207

Tel: +1-518-618-1030

USA - Canada Toll Free: 866-552-3453

Website: https://www.transparencymarketresearch.com/

About Us

Transparency Market Research is a global market intelligence company providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for several decision makers. Our experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.

Our data repository is continuously updated and revised by a team of research experts so that it always reflects latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Neuropathic Pain Management Market: Growing Incidence of Chronic Ailments to Propel the Global Market here

News-ID: 2066254 • Views:

More Releases from Transparency Market Research

Solid Tires Market Expected to Witness Impressive Growth at a 8.1% CAGR by 2031
Solid Tires Market Expected to Witness Impressive Growth at a 8.1% CAGR by 2031
The latest research study released by Transparency Market Research on "Solid Tires Market Forecast to 2023-2031 ″ research provides accurate economic, global, and country-level predictions and analyses. Solid Tires market is estimated to attain a valuation of US$ 760.0 Mn by the end of 2031, states a study by Transparency Market Research (TMR). Besides, the report notes that the market is prognosticated to expand at a CAGR of 8.1% during
Automotive Cyber security Market Sales Estimated to Hit USD 10.5 Billion by 2031| Says Transparency Market Research
Automotive Cyber security Market Sales Estimated to Hit USD 10.5 Billion by 2031 …
The latest research study released by Transparency Market Research on "𝐀𝐮𝐭𝐨𝐦𝐨𝐭𝐢𝐯𝐞 𝐂𝐲𝐛𝐞𝐫 𝐬𝐞𝐜𝐮𝐫𝐢𝐭𝐲 𝐌𝐚𝐫𝐤𝐞𝐭 𝐅𝐨𝐫𝐞𝐜𝐚𝐬𝐭 𝐭𝐨 𝟐𝟎𝟐𝟑-𝟐𝟎𝟑𝟏 ″ research provides accurate economic, global, and country-level predictions and analyses. It provides a comprehensive perspective of the competitive market as well as an in-depth supply chain analysis to assist businesses in identifying major changes in industry practices. The market report also examines the current state of the Automotive Cyber security industry, as
Ready-mix Concrete Market to Witness Exponential Growth with a CAGR of 6.1% from 2022 to 2031: TMR Study
Ready-mix Concrete Market to Witness Exponential Growth with a CAGR of 6.1% from …
The latest research study released by Transparency Market Research on "𝐑𝐞𝐚𝐝𝐲-𝐦𝐢𝐱 𝐂𝐨𝐧𝐜𝐫𝐞𝐭𝐞 𝐌𝐚𝐫𝐤𝐞𝐭 𝐅𝐨𝐫𝐞𝐜𝐚𝐬𝐭 𝐭𝐨 𝟐𝟎𝟐𝟑-𝟐𝟎𝟑𝟏 ″ research provides accurate economic, global, and country-level predictions and analyses. It provides a comprehensive perspective of the competitive market as well as an in-depth supply chain analysis to assist businesses in identifying major changes in industry practices. The market report also examines the current state of the Ready-mix Concrete industry, as well as
Mining Automation Market to Surge at 6.4% CAGR, Hitting US$ 7.3 Bn by 2031, According to TMR Study
Mining Automation Market to Surge at 6.4% CAGR, Hitting US$ 7.3 Bn by 2031, Acco …
The latest research study released by Transparency Market Research on "𝐌𝐢𝐧𝐢𝐧𝐠 𝐀𝐮𝐭𝐨𝐦𝐚𝐭𝐢𝐨𝐧 𝐌𝐚𝐫𝐤𝐞𝐭 𝐅𝐨𝐫𝐞𝐜𝐚𝐬𝐭 𝐭𝐨 𝟐𝟎𝟐𝟑-𝟐𝟎𝟑𝟏 ″ research provides accurate economic, global, and country-level predictions and analyses. It provides a comprehensive perspective of the competitive market as well as an in-depth supply chain analysis to assist businesses in identifying major changes in industry practices. The market report also examines the current state of the Mining Automation industry, as well as

All 5 Releases


More Releases for Pain

Global Pain Management Devices Market Study Analysis: Adoption Of Pain Managemen …
The fast-food market size was valued at $ billion in 2020 and is estimated to reach $ billion by 2028, growing at a CAGR of 6.3% during the forecast period. Pain is an unpleasant sensation and emotional experience caused due to actual or potential tissue damage or illness. Pain can be caused due to accidental injuries, or due to diseases like osteoarthritis, chronic arthritis, diabetic neuropathy, multiple sclerosis, stomach ulcer,
Flexotone Joint Pain Relief Reviews: Get Relief from Joint Pain & Arthritis
Joint pain & inflammation has come to be an instead usual problem among older consumers, as well as they are frequently entrusted to identify exactly how to deal with these problems with a topical cream or resting. Nevertheless, the makers behind Flexotone think that the reason behind this concern has every little thing to do with something that takes place within the joints. This trouble triggers unbelievable pain; however Big
Nerve Pain Treatment: 3 Top Neuropathy Pain Relief Pills
Neuropathy affects your extremities or nerves by producing tingling, discomfort, or numbness. Diabetics frequently suffer from neuropathy. According to the American Diabetes Association, around 65 percent of people suffering from diabetes face varying degrees of nerve damage, which results in diabetic neuropathy. Neuropathy can also occur due to different reasons, like alcoholism, trauma, or autoimmune disorders. Some people acquire neuropathy due to physical injury to their nerves, for instance. Others have
Post-operative Pain Management Market 2018 by Pain Type - Acute Pain, Moderate P …
Post-operative Pain Management Market 2018 Research Report implements an exhaustive study on Market Research Future. This Report Cover Key Market Driver, market size, growth rate, opportunities, market Dynamics and Overall Analysis. And also cover the other information such as Post-operative Pain Management Market trends, Prominent players, chapter-wise Description followed by various user perceptions and Forecast till 2023. Global Post-operative Pain Management Market - Overview Post-operative pain management is the most important part
Opioids – Reducing body pain but increasing pain for regulatory authorities
Opioids are drugs primarily prescribed for pain management and treatment of diarrhea and cough. Opioid drugs are of two types namely, agonist and antagonist. Codeine, Fentanyl, Meperidine, Methadone, Morphine, Hydrocodone, Diphenoxylate, Hydromorphone, Methylphenidate, Oxycodone, and Oxymorphone are classified as agonists, while Buprenorphine, Naloxone, Naltrexone, Methylnaltrexone, and Nalbuphine are classified as antagonists. Due to easy availability of opioids, these drugs are rampantly overused globally and the situation is more critical in
Middle East Tapentadol Market by Therapeutic Application Pain Management Neuropa …
Tapentadol is an opioid analgesic, indicated for severe pain management, on a daily or around the clock need for treatment and long-term opioid treatment, for which alternative treatment options are inadequate. Tapentadol is also indicated for neuropathic pain associated with diabetic peripheral neuropathy. It is widely used for management of acute, chronic, and cancer related pain among patients and is available legally on prescription. Nucynta ER is the first and